Decrease (-) Restore Default Increase (+)

Clinical Trials

Topic   Wound Care
Title   Use of Cytal® Wound Matrix and MicroMatrix® for the Management of Wounds
Summary   The main purpose of this study is to assess the effect of MicroMatrix and/or Cytal on wound healing.
Description   In this study, Cytal Wound Matrix 1-Layer will be applied to wounds, with MicroMatrix applied to fill the base of deep wounds. Patients with diverse wound types will be observed in the study, including patients with venous ulcers, diabetic foot ulcers, pressure ulcers, trauma wounds, external surgical wounds and wound dehiscence/surgical site infection. Patients may undergo weekly treatment for their wounds and can be treated with up to 10 applications of Cytal, with MicroMatrix when wound depth exceeds 3mm, within the first 12 weeks. If the patient has multiple wounds, the most appropriate wound that meets inclusion criteria and has at least 2cm of healthy tissue between itself and other wounds will be selected as the Study Wound.
IRB Number   1219793
Inclusion/Notes   To be eligible for this study, patients must meet several criteria, including but not limited to the following: patients must be 18 years or older; have at least one wound that the treating physician determines may be treated with Cytal with or without MicroMatrix; willing and able to adhere to protocol requirements; agree to participate in the study program; and comply with the study follow-up regimen.
Status   Open
Start Date   09/01/2018
Principal Name   Scott Gorenstein, MD
Contact Name   Raelina Howell, MD
Email   Raelina.Howell@nyulangone.org
Fax   516-663-2690
Current Trial Type   Interventional
Phone   516-663-8498
Alternate Phone   516-663-1669